Established in 2015, the Center for Vaccines and Immunology (CVI) provides an environment for world-class research and training in immunology. The CVI is advancing fundamental and translational immunological knowledge to develop new vaccines and therapies for infectious diseases and other immunity-related diseases and syndromes.
Infographic with Center for Vaccines & Immunology (CVI) surrounded by 5 main goals of center activity
Latest News
Collaborative research advances what is known about influenza B
UGA’s collaborative research explores the mystery of Influenza B, tracking the Victoria and Yamagata lineages to improve vaccine design and predict the virus’s future evolutionary path.
Vaccine elicitation of HIV broadly neutralizing antibodies from genome-edited B cells in non-human primates and derived lymphoid organoids
Gene Ther. April 2026
Cage-Side Blood Collections from the Ear Can Be Used for Hematological Evaluations in Japanese Macaques (Macaca fuscata)
J Am Assoc Lab Anim Sci. March 2026
Receptor-binding specificity and antigenic properties of a genotype D1.1 A (H5N1) influenza virus isolated from a human
Emerg Microbes Infect. March 2026
Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets
PLoS One. February 2026
PD-L1 is an intrinsic switch for natural killer cell-mediated, TRAIL-dependent antiviral function
Cell Rep. January 2026
Elicitation of Protective Immune Responses Against Influenza Virus Following Intranasal Delivery of Fluzone or Flublok Vaccines
Vaccines (Basel). January 2026
Contact Us
